Euclidean Capital LLC Top Holdings and 13F Report (2024)

About Euclidean Capital LLC

Euclidean Capital LLC has $779.98 million in total holdings as of March 31, 2024.
Euclidean Capital LLC owns shares of 13 different stocks, but just 2 companies or ETFs make up 80% of its holdings.
Approximately 3.86% of the portfolio was purchased this quarter.
About 25.26% of the portfolio was sold this quarter.
This quarter, Euclidean Capital LLC has purchased 13 new stocks and bought additional shares in 1 stock.
Euclidean Capital LLC sold shares of 1 stock and completely divested from 0 stocks this quarter.

Selling

Neutral

Buying

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
SPY SPDR S&P 500 ETF Trust	$509,805,468	$30,076,525 ▲	6.3%	974,641	65.4%	Finance
INDA iShares MSCI India ETF	$125,113,179		0.0%	2,425,144	16.0%	ETF
GLD SPDR Gold Shares	$88,926,790	$197,024,010 ▼	-68.9%	432,271	11.4%	Finance
ORIC ORIC Pharmaceuticals	$13,604,388		0.0%	989,410	1.7%	Medical
FHTX Foghorn Therapeutics	$10,559,936		0.0%	1,573,761	1.4%	Medical
ALEC Alector	$7,873,305		0.0%	1,307,858	1.0%	Medical
RAPT RAPT Therapeutics	$5,907,933		0.0%	657,899	0.8%	Medical
ME 23andMe	$5,449,341		0.0%	10,243,122	0.7%	Medical
TNYA Tenaya Therapeutics	$5,312,137		0.0%	1,015,705	0.7%	Medical
PMVP PMV Pharmaceuticals	$4,466,993		0.0%	2,627,643	0.6%	Medical
NGM NGM Biopharmaceuticals	$1,577,547		0.0%	992,168	0.2%	Medical
SURROZEN INC	$1,377,704		0.0%	87,696	0.2%	COM NEW
SRZNW Surrozen	$5,159		0.0%	170,833	0.0%	Medical